What does CUSIP 67576A100 represent in this 13F holders report?

CUSIP 67576A100 is the security identifier for OCUL - OCULAR THERAPEUTIX, INC - Common Stock used to aggregate holder disclosures.

How many institutions held OCUL - OCULAR THERAPEUTIX, INC - Common Stock in Q2 2021?

146 institutional investors reported OCUL - OCULAR THERAPEUTIX, INC - Common Stock for Q2 2021. Use the holders table for investor-level position and value details.

OCULAR THERAPEUTIX, INC - Common Stock (OCUL)

CUSIP: 67576A100

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock
Shares outstanding: 214,467,875
Total 13F shares: 48,348,304
Share change: +1,200,422
Total reported value: $685,490,035
Put/Call ratio: 39%
Price per share: $14.18
Number of holders: 146
Value change: +$13,999,445
Number of buys: 81
Number of sells: 59

Quarterly Holders Quick Answers

What is CUSIP 67576A100?
CUSIP 67576A100 identifies OCUL - OCULAR THERAPEUTIX, INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 67576A100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of OCUL - OCULAR THERAPEUTIX, INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Opaleye Management Inc.	13F	Company	3%	6,480,000	$106,337,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	2.7%	5,867,062	$96,278,000	—	31 Mar 2021	13F
SUMMER ROAD LLC	13F	Company	2.6%	5,618,861	$92,206,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	1.7%	3,643,063	$59,782,000	—	31 Mar 2021	13F
DELTEC ASSET MANAGEMENT LLC	13F	Company	0.98%	2,096,341	$34,401,000	—	31 Mar 2021	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.72%	1,548,627	$25,414,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	0.71%	1,517,617	$24,904,000	—	31 Mar 2021	13F
EMERALD MUTUAL FUND ADVISERS TRUST	13F	Company	0.63%	1,353,896	$22,217,000	—	31 Mar 2021	13F
EMERALD ADVISERS, LLC	13F	Company	0.6%	1,294,850	$21,248,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.57%	1,229,608	$20,177,000	—	31 Mar 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.57%	1,222,300	$20,058,000	—	31 Mar 2021	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.54%	1,168,458	$19,174,000	—	31 Mar 2021	13F
GREAT POINT PARTNERS LLC	13F	Company	0.47%	1,007,012	$16,525,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	0.37%	788,944	$12,946,000	—	31 Mar 2021	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	0.35%	750,000	$12,308,000	—	31 Mar 2021	13F
D. E. Shaw & Co., Inc.	13F	Company	0.3%	652,128	$10,701,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.3%	637,749	$10,465,000	—	31 Mar 2021	13F
IEQ CAPITAL, LLC	13F	Company	0.29%	628,933	$10,321,000	—	31 Mar 2021	13F
UBS Group AG	13F	Company	0.26%	550,864	$9,039,000	—	31 Mar 2021	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.25%	535,332	$8,785,000	—	31 Mar 2021	13F
CASTLEARK MANAGEMENT LLC	13F	Company	0.23%	485,837	$7,973,000	—	31 Mar 2021	13F
Endurant Capital Management LP	13F	Company	0.2%	438,933	$7,203,000	—	31 Mar 2021	13F
Kamunting Street Capital Management, L.P.	13F	Company	0.2%	436,307	$7,160,000	—	31 Mar 2021	13F
Ikarian Capital, LLC	13F	Company	0.2%	419,573	$6,885,000	—	31 Mar 2021	13F
Rubric Capital Management LP	13F	Company	0.18%	382,386	$6,275,000	—	31 Mar 2021	13F
MORGAN STANLEY	13F	Company	0.16%	334,303	$5,486,000	—	31 Mar 2021	13F
Altium Capital Management LLC	13F	Company	0.15%	326,174	$5,313,000	—	31 Mar 2021	13F
FEDERATED HERMES, INC.	13F	Company	0.15%	313,238	$5,140,000	—	31 Mar 2021	13F
Bank of New York Mellon Corp	13F	Company	0.12%	257,917	$4,232,000	—	31 Mar 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.12%	257,023	$4,218,000	—	31 Mar 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.12%	254,951	$4,184,000	—	31 Mar 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.11%	242,297	$3,977,000	—	31 Mar 2021	13F
Affinity Asset Advisors, LLC	13F	Company	0.11%	227,500	$3,733,000	—	31 Mar 2021	13F
Lisanti Capital Growth, LLC	13F	Company	0.09%	194,800	$3,197,000	—	31 Mar 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.09%	194,295	$3,188,000	—	31 Mar 2021	13F
NOTTINGHAM ADVISORS, INC.	13F	Company	0.09%	194,266	$3,188,000	—	31 Mar 2021	13F
FMR LLC	13F	Company	0.09%	184,853	$3,033,000	—	31 Mar 2021	13F
Swiss National Bank	13F	Company	0.06%	138,600	$2,274,000	—	31 Mar 2021	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.06%	123,000	$2,018,000	—	31 Mar 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.05%	109,936	$1,804,000	—	31 Mar 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.05%	108,081	$1,774,000	—	31 Mar 2021	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.05%	101,800	$1,671,000	—	31 Mar 2021	13F
Quilter Plc	13F	Company	0.05%	97,915	$1,607,000	—	31 Mar 2021	13F
Assenagon Asset Management S.A.	13F	Company	0.04%	95,895	$1,574,000	—	31 Mar 2021	13F
BROWN ADVISORY INC	13F	Company	0.04%	90,000	$1,477,000	—	31 Mar 2021	13F
SEI INVESTMENTS CO	13F	Company	0.04%	75,250	$1,476,000	—	31 Mar 2021	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.04%	86,600	$1,421,000	—	31 Mar 2021	13F
RHUMBLINE ADVISERS	13F	Company	0.04%	83,526	$1,371,000	—	31 Mar 2021	13F
US BANCORP \DE\	13F	Company	0.04%	82,972	$1,362,000	—	31 Mar 2021	13F
ROYAL BANK OF CANADA	13F	Company	0.04%	79,702	$1,309,000	—	31 Mar 2021	13F

Institutional Holders of OCULAR THERAPEUTIX, INC - Common Stock (OCUL) as of Q2 2021

As of 30 Jun 2021, OCULAR THERAPEUTIX, INC - Common Stock (OCUL) was held by 146 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 48,348,304 shares. The largest 10 holders included Opaleye Management Inc., SUMMER ROAD LLC, BlackRock Inc., VANGUARD GROUP INC, DELTEC ASSET MANAGEMENT LLC, Rubric Capital Management LP, STATE STREET CORP, EMERALD MUTUAL FUND ADVISERS TRUST, GEODE CAPITAL MANAGEMENT, LLC, and EMERALD ADVISERS, LLC. This page lists 147 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

149

Q2 2021 holders

146

Holder diff

-3

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.